Arcutis Biotherapeutics, Inc. (ARQT)

NASDAQ: ARQT · Real-Time Price · USD

28.84

-0.26 (-0.89%)

At close: Oct 16, 2026, 4:00 PM EDT

28.37

-0.47 (-1.64%)

After-hours: Oct 16, 2026, 7:58 PM EDT

Arcutis Biotherapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Revenue	461.98	372.07	166.54	29.19	3.69	-
Other Revenue	2	4	30	30.42	-	-
Revenue	463.98	376.07	196.54	59.61	3.69	-
Revenue Growth	76.11%	91.34%	229.73%	1517.09%	-	-
Cost of Revenue	41.1	36.7	19.13	4.99	0.75	-
Gross Profit	422.89	339.38	177.41	54.62	2.93	-
Selling, General & Admin	297.6	274.55	229.39	185.15	122.12	60.97
Research & Development	91.04	77.05	76.42	110.58	182.44	145.56
Operating Expenses	388.63	351.6	305.81	295.72	304.56	206.53
Operating Income	34.25	-12.23	-128.4	-241.1	-301.63	-206.53
Interest Expense	-13.85	-12.08	-27.17	-29.71	-15.65	-
Interest & Investment Income	8.84	8.9	16.13	12.52	5.82	0.17
Other Non Operating Income (Expenses)	0.05	0.44	0.05	-0.73	-	-
Pretax Income	29.3	-14.97	-139.39	-259.03	-311.46	-206.36
Income Tax Expense	0.78	1.17	0.65	3.11	-	-
Net Income	28.52	-16.14	-140.04	-262.14	-311.46	-206.36
Net Income to Common	28.52	-16.14	-140.04	-262.14	-311.46	-206.36
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	129	127	121	69	55	49
Shares Outstanding (Diluted)	132	127	121	69	55	49
Shares Change	5.07%	5.19%	74.53%	25.94%	11.39%	38.52%
EPS (Basic)	0.22	-0.13	-1.16	-3.78	-5.66	-4.18
EPS (Diluted)	0.22	-0.13	-1.16	-3.78	-5.66	-4.18
EPS Growth	-	-	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	39.15	-6.31	-112.3	-247.49	-258.05	-175.62
Free Cash Flow Per Share	0.30	-0.05	-0.93	-3.57	-4.69	-3.56
Gross Margin	91.14%	90.24%	90.27%	91.63%	79.54%	-
Operating Margin	7.38%	-3.25%	-65.33%	-404.49%	-8183.04%	-
Profit Margin	6.15%	-4.29%	-71.25%	-439.79%	-8449.76%	-
Free Cash Flow Margin	8.44%	-1.68%	-57.14%	-415.20%	-7000.76%	-
EBITDA	36.5	-7.56	-126.44	-240.35	-300.69	-206.08
EBITDA Margin	7.87%	-2.01%	-64.33%	-	-	-
D&A For EBITDA	2.25	4.67	1.96	0.75	0.93	0.45
EBIT	34.25	-12.23	-128.4	-241.1	-301.63	-206.53
EBIT Margin	7.38%	-3.25%	-65.33%	-	-	-
Revenue as Reported	463.98	376.07	196.54	59.61	3.69	-
Advertising Expenses	-	25.3	6.9	11.2	1.5	-

SEC Filings: 10-K · 10-Q